Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Grekowitz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Allergy|June 30, 2022
Disease Impact, Diagnostic Delay, and Unmet Medical Needs of Patients With Cholinergic Urticaria in German-Speaking CountriesSabine Altrichter, Emilia Mellerowicz, Dorothea Terhorst-Molawi, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 5, 2024
Skin reaction patterns in cholinergic urticariaIlona Shurmelova, Agata Baldyga, Eva Grekowitz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 18, 2024
Validation of the Cholinergic Urticaria Activity Score (CholUAS)Pia Schnarkowski, Pascale Salameh, Eva Grekowitz, et al.
Allergy|July 26, 2024
An algorithm for the diagnosis and treatment of chronic inducible urticaria, 2024 updateMarcus Maurer, Hanna Bonnekoh, Eva Grekowitz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 16, 2025
Validation of the Urticaria Activity Score for Cold Urticaria (ColdUAS)Eva Grekowitz, Pascale Salameh, Sabine Altrichter, et al.
The British Journal of Dermatology|February 3, 2024
Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trialEva Grekowitz, Martin Metz, Sabine Altrichter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 28, 2026
Differential susceptibility of hair colour changes after barzolvolimabMelba Muñoz, Jimmy Zhou, Hanna Bonnekoh, et al.
Allergy|November 17, 2022
Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticariaDorothea Terhorst-Molawi, Tomasz Hawro, Eva Grekowitz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 5, 2024
The Mastocytosis Control Test: A Patient-Reported Outcome Measure Assessing Disease ControlFrank Siebenhaar, Senan Sofi, Sophia Neisinger, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 10, 2025
Development and Validation of a Disease Severity Index for Patients with Cold UrticariaTatjana Altunergi, Manuel P Pereira, Sabine Altrichter, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Allergy|June 30, 2022
Disease Impact, Diagnostic Delay, and Unmet Medical Needs of Patients With Cholinergic Urticaria in German-Speaking CountriesSabine Altrichter, Emilia Mellerowicz, Dorothea Terhorst-Molawi, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 5, 2024
Skin reaction patterns in cholinergic urticariaIlona Shurmelova, Agata Baldyga, Eva Grekowitz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 18, 2024
Validation of the Cholinergic Urticaria Activity Score (CholUAS)Pia Schnarkowski, Pascale Salameh, Eva Grekowitz, et al.
Allergy|July 26, 2024
An algorithm for the diagnosis and treatment of chronic inducible urticaria, 2024 updateMarcus Maurer, Hanna Bonnekoh, Eva Grekowitz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 16, 2025
Validation of the Urticaria Activity Score for Cold Urticaria (ColdUAS)Eva Grekowitz, Pascale Salameh, Sabine Altrichter, et al.
The British Journal of Dermatology|February 3, 2024
Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trialEva Grekowitz, Martin Metz, Sabine Altrichter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 28, 2026
Differential susceptibility of hair colour changes after barzolvolimabMelba Muñoz, Jimmy Zhou, Hanna Bonnekoh, et al.
Allergy|November 17, 2022
Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticariaDorothea Terhorst-Molawi, Tomasz Hawro, Eva Grekowitz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 5, 2024
The Mastocytosis Control Test: A Patient-Reported Outcome Measure Assessing Disease ControlFrank Siebenhaar, Senan Sofi, Sophia Neisinger, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 10, 2025
Development and Validation of a Disease Severity Index for Patients with Cold UrticariaTatjana Altunergi, Manuel P Pereira, Sabine Altrichter, et al.
Pageof 1